e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Difficult-to-treat respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical analysis of pulmonary Mycobacterium kansasii disease
Y. Kobashi (Kurashiki, Japan), R. Shirai (Kurashiki, Japan), S. Kato (Kurashiki, Japan), M. Oka (Kurashiki, Japan)
Source:
International Congress 2018 – Difficult-to-treat respiratory infections
Session:
Difficult-to-treat respiratory infections
Session type:
Thematic Poster
Number:
4711
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kobashi (Kurashiki, Japan), R. Shirai (Kurashiki, Japan), S. Kato (Kurashiki, Japan), M. Oka (Kurashiki, Japan). Clinical analysis of pulmonary Mycobacterium kansasii disease. 4711
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Clinical features of pulmonary
Mycobacterium avium intracellulare
complex disease with a solitary pulmonary nodule in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005
Mycobacterium xenopi pulmonary disease in Croatia
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005
Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA
Source: Eur Respir J 2013; 42: 454-460
Year: 2013
Emerging untreatable non-tuberculous pulmonary disease due to
Mycobacterium abscessus
Source: Eur Respir J 2004; 24: Suppl. 48, 415s
Year: 2004
Management of
Mycobacterium avium
complex and
Mycobacterium abscessus
pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022
Clinical features of radiologically atypical Mycobacterium kansasii lung disease in Japan
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Combined chemotherapy in
Mycobacterium avium
complex pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 657s
Year: 2005
Long-term survival of patients with
mycobacterium avium- intracellulare
complex pulmonary disease (MAC-PD)
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection
Source: Eur Respir J 2015; 46: 1823-1826
Year: 2015
Clinical study of mycobacterium avium complex pulmonary disease complicated by interstitial pneumonia
Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections
Year: 2011
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Source: Eur Respir J 2009; 34: 926-931
Year: 2009
Isolation of
M. abscessus
from patients with
M. avium
complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008
Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept